New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Some long-time 340B advocates have warned that a new federal bill based on input from an alliance of the drug [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A subcommittee of the House Energy and Commerce (E&C) Committee, which is tasked with overseeing the 340B drug discount program, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Rhode Island Senate yesterday approved legislation that would prohibit 340B contract pharmacy restrictions in that state, sending it to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Ohio Community Health Center CEOs, Lawmakers Urge Passage of State Contract Pharmacy Protection Bill
Ohio federally qualified health center (FQHC) leaders called on state lawmakers Tuesday to pass newly introduced legislation that would end [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program based on recommendations from a nonprofit group [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...] …